Stoke Therapeutics (0GT.STU) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-0.69
-0.68
-0.68
-0.67

Details

Expected EPS
-0.6885310250000001
Actual EPS
-0.6736093000000001
Surprise EPS
0.01
Surprise Percent
+2.17%

Description

Stoke Therapeutics (0GT.STU) has reported earnings of -0.6736093000000001 per share for Q2 2026.

0 Comments

Share your thoughts